Clinical Trials

Auto Added by WPeMatico

How an Unproven Alzheimer’s Drug Got Approved

How an Unproven Alzheimer’s Drug Got ApprovedThough some of its own senior officials said there was little evidence of benefit for patients, the F.D.A. nonetheless greenlighted Biogen’s Aduhelm, or aducanumab.http://rss.nytimes.com/services/xml/rss/nyt/Technology.xmlNYT > Technologyhttps://static01.nyt.com/images/misc/NYT_logo_rss_250x40.pngTechnology124Pam Belluck, Sheila Kaplan and Rebecca Robbins Powered by WPeMatico

How an Unproven Alzheimer’s Drug Got Approved Read More »

W.H.O. Experts Seek Limits on Human Gene-Editing Experiments

W.H.O. Experts Seek Limits on Human Gene-Editing ExperimentsThe panel also called on countries to ensure that beneficial forms of genetic alteration be shared equitably.http://rss.nytimes.com/services/xml/rss/nyt/Technology.xmlNYT > Technologyhttps://static01.nyt.com/images/misc/NYT_logo_rss_250x40.pngTechnology124Gina Kolata Powered by WPeMatico

W.H.O. Experts Seek Limits on Human Gene-Editing Experiments Read More »

London A.I. Lab Claims Breakthrough That Could Accelerate Drug Discovery

London A.I. Lab Claims Breakthrough That Could Accelerate Drug DiscoveryResearchers at DeepMind say they have solved “the protein folding problem,” a task that has bedeviled scientists for more than 50 years.http://rss.nytimes.com/services/xml/rss/nyt/Technology.xmlNYT > Technologyhttps://static01.nyt.com/images/misc/NYT_logo_rss_250x40.pngTechnology124Cade Metz Powered by WPeMatico

London A.I. Lab Claims Breakthrough That Could Accelerate Drug Discovery Read More »

Scroll to Top